Cyclophosphamide and mercaptoethane sulfonate therapy for minimal lesion glomerulonephritis.
Kleta
R
R
D003520:Cyclophosphamide / Q000627:therapeutic use*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015080:Mesna / Q000627:therapeutic use*; D020011:Protective Agents / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D020011:Protective Agents; D003520:Cyclophosphamide; D015080:Mesna